ICE Shock Gloves: Army Findings and Civilian Safety Questions

Newstro examines ICE's shock-glove procurement, the Army's limited operational assessment, and questions about civilian safety. The report separates rapid compliance during military testing from comprehensive clinical evidence and explains ICE's stated rationale for the purchase. The procurement justification lists 6,000 operational glove units at $2,495 each, 650 training units, and additional equipment and support, for a total of $16,700,640. It describes a six-month base period and a sole-source purchase from Compliant Technologies. The Army's public summary places the assessment at Fort Leavenworth on October 21–23, 2024. It describes rapid compliance, reduced team fatigue and a limited sample. The summary also records a safety review and a release for the exercise. These operational findings and that exercise-specific release do not, by themselves, establish comprehensive clinical safety for civilian populations. American Oversight questions whether the testing establishes civilian safety. ICE's justification emphasizes de-escalation, reducing higher levels of force, training and accountability. Reporting snapshot: October 7, 2026. Rollout status is attributed to AP's October 6 reporting. Source scope: Newstro reviewed the four-page Army summary and ICE's seven-page procurement justification. The full underlying limited-user-assessment enclosure was not independently reviewed; the watchdog's account is attributed accordingly. The procurement justification describes the acquisition scope and rationale, rather than serving as an award certificate or proof of completed delivery. Like this video, subscribe to Newstro, and ring the notification bell for more Newstro videos.